Showing results (441-450 of 487) with videos related to
Sort By:
Pageof 49
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow supportT C Shea, M Flaherty, A Elias, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancerL J Ayash, C Wheeler, D Fairclough, et al.Anti-Cancer Drugs|December 24, 1997
Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing ratsG Stehle, A Wunder, H Sinn, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1984
Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in cultureE Frei, A Rosowsky, J E Wright, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1986
Determination of DNA single strand breaks and selective DNA amplification by N-nitrodimethylamine and analogs, and estimation of the indicator cells' metabolic capacitiesE Frei, B L Pool, H R Glatt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcomeA Elias, J Ibrahim, A T Skarin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapyI Tepler, S A Cannistra, E Frei, et al.Bone Marrow Transplantation|March 1, 1995
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell supportA D Elias, L J Ayash, C Wheeler, et al.Medical and Pediatric Oncology|January 1, 1976
Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary reportL Furman, B M Camitta, N Jaffe, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patientsJ P Eder, A D Elias, L Ayash, et al.Pageof 49